리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 05월
페이지 정보:영문 384 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 신경외과 시장은 2030년까지 51억 달러에 달할 전망
2024년에 43억 달러로 추정되는 세계의 신경외과 시장은 분석 기간인 2024-2030년에 CAGR 3.1%로 성장하며, 2030년에는 51억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 신경 중재적 디바이스는 CAGR 4.0%를 기록하며, 분석 기간 종료까지 14억 달러에 달할 것으로 예측됩니다. 신경 내시경 부문의 성장률은 분석 기간 중 CAGR 3.7%로 추정됩니다.
미국 시장은 12억 달러, 중국은 CAGR 6.0%로 성장 예측
미국의 신경외과 시장은 2024년에 12억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 6.0%로 2030년까지 10억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.2%와 2.4%로 예측됩니다. 유럽에서는 독일이 CAGR 1.8%로 성장할 것으로 예측됩니다.
세계의 신경외과 시장 - 주요 동향과 촉진요인 정리
왜 신경외과는 전 세계 외과 진료에서 정밀성 중심의 분야로 진화하고 있는가?
신경외과는 뇌, 척추, 말초신경에 영향을 미치는 질환의 외과적 치료에 관한 의료 전문 분야이지만, 정밀의료, 첨단 영상 진단, 최소침습기술로 인해 큰 변화가 일어나고 있습니다. 과거 신경외과는 생명을 위협하는 응급수술이나 고위험 종양절제술이 주요 대상이었으나, 현재는 뇌심부자극술, 척수감압술, 간질수술, 뇌졸중 및 동맥류에 대한 혈관내 치료 등 광범위한 선택적 및 수복적 수술을 포괄하고 있습니다.
세계에서 신경질환, 외상, 척추질환, 신경종양 사례가 증가함에 따라 선진국과 신흥 국가 모두에서 신경외과 서비스에 대한 수요가 증가하고 있습니다. 인구 고령화, 퇴행성 척추 질환, 뇌졸중, 뇌종양에 대한 부담이 증가함에 따라 신경외과는 종합적인 신경학적 치료에 필수적인 분야가 되고 있습니다. 또한 로봇 공학, 내비게이션 시스템, 수술 중 모니터링의 도입으로 복잡한 수술이 보다 안전하고, 재현성이 높으며, 덜 침습적인 수술이 가능해짐에 따라 신경외과의 회복 및 기능적 결과에서 신경외과의 역할이 확대되고 있습니다.
로봇공학, 영상기술, 데이터 통합은 신경외과수술의 정확성과 안전성을 어떻게 향상시키고 있는가?
기술의 발전은 신경외과수술의 운영 상황을 재정의하고 있습니다. 수술 중 MRI, 신경 내비게이션, 로봇 보조 시스템은 종양 절제, 전극 배치, 척수 기구 장착에 있으며, 밀리미터 단위의 정확도를 가능하게 하고 있습니다. 이러한 기술을 통해 외과의사는 3D 재구성을 통해 수술 계획을 세우고, 다양한 수술 경로를 시뮬레이션하고, 실시간 해부학적 변화에 따라 수술 중 적응할 수 있습니다. 영상 유도 수술(IGS)은 최소 침습 개두술과 내시경 경비강 두개저 수술에 점점 더 많이 사용되고 있으며, 부수적인 손상을 줄이고 신경학적 결과를 개선하고 있습니다.
인공지능(AI)과 머신러닝은 수술 전 계획, 수술 중 의사결정 지원, 수술 후 위험도 평가에 적용되고 있으며, AI를 통한 세분화 툴은 중요한 뇌 영역을 식별하는 데 도움이 되고, 예측 모델은 수술 합병증과 회복 기간을 예측하는 데 도움을 줍니다. 또한 전자의무기록, 수술 영상 분석, 신경생리학적 데이터의 통합은 다학제적 치료와 장기적인 결과 추적을 강화하고 있습니다. 이러한 기술 혁신은 수술의 정확성을 향상시킬 뿐만 아니라, 원격 학습 및 증강현실 교육 플랫폼을 통해 신경외과 전문 지식을 민주화하고 있습니다.
뇌신경외과 서비스에 대한 전 세계 수요를 형성하는 환자 부문과 의료 시스템은 무엇인가?
신경외과는 뇌종양, 외상성 뇌손상, 뇌졸중 관련 출혈, 뇌수두증, 뇌전증, 간질, 척추 추간판 질환, 키아리 기형이나 척추이분증과 같은 선천성 기형 등 다양한 환자군을 진료하고 있습니다. 특히 퇴행성 척추수술, 뇌혈관 수술, 종양절제술 등에서는 신경외과 환자 중 고령자의 비율이 증가하고 있습니다. 소아신경외과 역시 선천성 기형이나 신경발달장애에 대응하는 중요한 서브 스페셜리티임에는 변함이 없습니다.
북미가 세계 신경외과 시장을 선도하고 있는 것은 첨단화된 병원 인프라, 많은 수술 건수, 수술 기구의 지속적인 기술 혁신에 기인합니다. 유럽은 강력한 공공 의료 자금과 영상 유도 및 로봇 신경외과 시스템의 보급으로 근소한 차이로 그 뒤를 잇고 있습니다. 아시아태평양은 특히 인도, 중국, 한국, 일본을 중심으로 빠르게 성장하고 있으며, 환자 수 증가, 신경외과 교육 프로그램 개선, 의료보험 적용률 증가가 그 원동력이 되고 있습니다. 라틴아메리카, 중동 및 아프리카의 신흥 시장에서는 의료관광, 민관 파트너십, 외과 선교 프로그램을 통해 신경외과 의료에 대한 투자가 이루어지고 있습니다.
신경외과 시장의 장기적인 성장과 다직종 통합의 원동력은?
신경외과 시장 성장의 원동력은 전 세계 신경 및 척추 질환의 부담 증가, 수술 기술의 발전, 최소침습 및 기능 보존 수술로의 이동입니다. 신경외과 전문의, 신경과 전문의, 영상의학과 전문의, 마취과 전문의, 재활의학과 전문의의 협진이 진행되어 환자의 예후를 개선하고 회복을 앞당기는 종합적인 연속 치료가 실현되고 있습니다.
향후 성장은 기능적 신경외과(운동장애, 정신질환, 통증 등), 뇌-컴퓨터 인터페이스, 이식형 신경자극장비의 동향에 의해 형성될 것입니다. 로봇에 의한 자동화, 클라우드 기반 수술 데이터 플랫폼, 원격 뇌신경 수술은 수술의 범위와 수술의 효율성을 높일 것으로 보입니다. 신경외과는 정밀성, 개인화, 다영역성으로 계속 진화하고 있으며, 세계 현대 의학에서 역동적이고 필수적인 기둥으로 남을 것입니다.
부문
제품 유형(신경 중재적 디바이스, 신경 내시경, 신경외과용 드릴, 방사선 수술 시스템, 경막 대체물, 기타 제품 유형), 적응증(뇌종양 적응증, 척추·두개저 종양 적응증, 외상성 뇌손상 적응증, 두개 안면 외상 적응증, 기타 적응증), 최종 용도(병원·전문 클리닉 최종 용도, 외래 수술 센터 최종 용도, 기타 최종 용도)
조사 대상 기업의 예(합계 36 주목 기업)
Abbott Laboratories
Adeor Medical AG
Aleva Neurotherapeutics
B. Braun Melsungen AG
Boston Scientific Corporation
Brainlab AG
Elekta AB
Integra LifeSciences Holdings Corp.
Johnson & Johnson(DePuy Synthes)
Karl Storz SE & Co. KG
LivaNova PLC
Machida Endoscope Co., Ltd.
Medtronic plc
MicroVention Inc.(Terumo Group)
NuVasive, Inc.
Penumbra, Inc.
Smith & Nephew plc
Stryker Corporation
Synaptive Medical Inc.
Zimmer Biomet Holdings, Inc.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수입원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.
Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.
2025년 4월: 협상 단계
이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.
2025년 7월: 최종 관세 재설정
고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.
상호 및 양자 간 무역과 관세의 영향 분석 :
미국 <>중국 <>멕시코 <>캐나다 <>EU <>일본 <>인도 <>기타 176개국
업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량경제 상황에서 이 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Neurosurgery Market to Reach US$5.1 Billion by 2030
The global market for Neurosurgery estimated at US$4.3 Billion in the year 2024, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Neuro Interventional Devices, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Neuroendoscopes segment is estimated at 3.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 6.0% CAGR
The Neurosurgery market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.
Global Neurosurgery Market - Key Trends & Drivers Summarized
Why Is Neurosurgery Evolving into a Precision-Centric Discipline Within Global Surgical Practice?
Neurosurgery, the medical specialty concerned with the surgical treatment of disorders affecting the brain, spine, and peripheral nerves, is undergoing a major transformation fueled by precision medicine, advanced imaging, and minimally invasive techniques. Once associated primarily with life-threatening emergencies or high-risk tumor resections, neurosurgery now encompasses a wide spectrum of elective and restorative procedures, including deep brain stimulation, spinal decompression, epilepsy surgery, and endovascular interventions for stroke and aneurysms.
The global rise in neurological diseases, traumatic injuries, spinal disorders, and neuro-oncological cases has increased the demand for neurosurgical services across both developed and developing economies. With populations aging and the burden of degenerative spinal disease, stroke, and brain tumors increasing, neurosurgery is becoming an essential part of integrated neurological care. Moreover, the incorporation of robotics, navigation systems, and intraoperative monitoring is making complex surgeries safer, more reproducible, and less invasive, expanding the role of neurosurgery in restorative and functional outcomes.
How Are Robotics, Imaging Technologies, and Data Integration Enhancing Neurosurgical Precision and Safety?
Technological advances are redefining the operational landscape of neurosurgery. Intraoperative MRI, neuronavigation, and robotic-assisted systems are enabling millimeter-level accuracy in tumor resections, electrode placement, and spinal instrumentation. These technologies allow surgeons to plan procedures with 3D reconstructions, simulate different surgical paths, and adapt intraoperatively based on real-time anatomical shifts. Image-guided surgery (IGS) is increasingly used in minimally invasive craniotomies and endoscopic transnasal skull base procedures, reducing collateral damage and improving neurological outcomes.
Artificial intelligence (AI) and machine learning are being applied to preoperative planning, intraoperative decision support, and postoperative risk assessment. AI-driven segmentation tools help identify critical brain regions, while predictive models assist in forecasting surgical complications or recovery timelines. Additionally, the integration of electronic health records, surgical video analysis, and neurophysiological data is enhancing multidisciplinary care and long-term outcome tracking. These innovations are not only elevating procedural accuracy but also democratizing neurosurgical expertise through remote learning and augmented reality training platforms.
Which Patient Segments and Healthcare Systems Are Shaping Global Demand for Neurosurgical Services?
Neurosurgery caters to a broad spectrum of patient populations, including individuals with brain tumors, traumatic brain injuries, stroke-related hemorrhages, hydrocephalus, epilepsy, spinal disc disease, and congenital malformations such as Chiari malformations or spina bifida. The elderly account for a growing proportion of neurosurgical patients, particularly for degenerative spine surgeries, cerebrovascular procedures, and tumor resections. Pediatric neurosurgery also remains a vital sub-specialty, addressing congenital anomalies and neurodevelopmental disorders.
North America leads the global neurosurgery market due to advanced hospital infrastructure, high surgical volumes, and continuous innovation in surgical devices. Europe follows closely, with strong public health funding and widespread adoption of image-guided and robotic neurosurgical systems. Asia-Pacific is rapidly expanding, particularly in India, China, South Korea, and Japan, driven by increasing patient volumes, improved neurosurgical training programs, and rising health insurance coverage. Emerging markets in Latin America, the Middle East, and Africa are investing in neurosurgical capacity through medical tourism, public-private partnerships, and surgical mission programs.
What Is Driving Long-Term Growth and Multidisciplinary Integration in the Neurosurgery Market?
The growth in the neurosurgery market is driven by the escalating global burden of neurological and spinal disorders, advancements in surgical technology, and the movement toward minimally invasive and function-preserving procedures. Increasing collaboration between neurosurgeons, neurologists, radiologists, anesthesiologists, and rehabilitation specialists is creating a holistic continuum of care that enhances patient outcomes and accelerates recovery.
Future growth will be shaped by trends in functional neurosurgery (e.g., for movement disorders, psychiatric conditions, and pain), brain-computer interfaces, and implantable neurostimulators. Robotic automation, cloud-based surgical data platforms, and tele-neurosurgery will enhance surgical reach and operational efficiency. As neurosurgery continues to evolve toward precision, personalization, and multidisciplinarity, it is poised to remain a dynamic and indispensable pillar of modern medical intervention worldwide.
SCOPE OF STUDY:
The report analyzes the Neurosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes, Other Product Types); Indication (Brain Cancer Indication, Spine & Skull Base Tumors Indication, Traumatic Brain Injuries Indication, Craniofacial Trauma Indication, Other Indications); End-Use (Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 36 Featured) -
Abbott Laboratories
Adeor Medical AG
Aleva Neurotherapeutics
B. Braun Melsungen AG
Boston Scientific Corporation
Brainlab AG
Elekta AB
Integra LifeSciences Holdings Corp.
Johnson & Johnson (DePuy Synthes)
Karl Storz SE & Co. KG
LivaNova PLC
Machida Endoscope Co., Ltd.
Medtronic plc
MicroVention Inc. (Terumo Group)
NuVasive, Inc.
Penumbra, Inc.
Smith & Nephew plc
Stryker Corporation
Synaptive Medical Inc.
Zimmer Biomet Holdings, Inc.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Neurosurgery - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Burden of Neurological Disorders Spurs Growth in Neurosurgical Procedures
Advances in Intraoperative Navigation Systems Strengthen Precision and Surgical Confidence
Increased Adoption of Robot-Assisted Neurosurgery Drives Efficiency and Patient Outcomes
Expansion of Neuroendoscopic Techniques Propels Minimally Invasive Surgical Interventions
Growing Utilization of 3D Imaging and AR/VR Platforms Enhances Pre-Surgical Planning Accuracy
Rise in Traumatic Brain Injuries and Spinal Disorders Expands Addressable Patient Pool
Integration of AI in Neurosurgical Workflows Throws the Spotlight on Predictive Analytics
Global Expansion of Neurosurgery Centers in Emerging Economies Drives Market Penetration
Improved Training Through Simulators and Virtual Labs Enhances Surgeon Proficiency and Case Volume
Development of Cost-Effective Neurosurgical Tools Supports Accessibility in Resource-Constrained Settings
Regulatory Approvals of Navigation-Assisted Implants Accelerate Technology Adoption
Growth in Awake Craniotomy Procedures Enhances Functional Outcomes and Recovery Metrics
Increased Clinical Focus on Pediatric Neurosurgery Supports Early Intervention Protocols
Postoperative Recovery Technologies Propel Demand for Comprehensive Surgical Ecosystems
Surge in Brain Tumor and Epilepsy Resections Drives Procedure-Specific Tool Demand
Rising Investment in Neurovascular Surgery Supports Treatment of Aneurysms and AVMs
Expansion of Hospital Neuroscience Programs Enhances Institutional Capacity and Case Load
Heightened Awareness of Neurosurgical Advancements Spurs Patient Willingness for Early Treatment
Variability in Neurosurgical Reimbursement Structures Creates Regional Access Inequities
Advancements in Neuro-monitoring Tools Support Real-Time Intraoperative Decision-Making
Global Initiatives for Stroke and Neurotrauma Management Reinforce Surgical Infrastructure Development
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Neurosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Neuro Interventional Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Neuro Interventional Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Neuro Interventional Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Neuroendoscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Neuroendoscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Neuroendoscopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Neurosurgical Drills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Neurosurgical Drills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Neurosurgical Drills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Radiosurgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Radiosurgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Radiosurgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Dura Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Dura Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Dura Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Craniofacial Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Craniofacial Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Craniofacial Trauma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Brain Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Brain Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Brain Cancer Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Spine & Skull Base Tumors Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Spine & Skull Base Tumors Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Spine & Skull Base Tumors Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Traumatic Brain Injuries Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Traumatic Brain Injuries Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Traumatic Brain Injuries Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Hospitals & Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Hospitals & Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Hospitals & Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 47: USA Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: USA Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: USA 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Canada 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: Japan 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 74: China Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: China Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: China 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 83: Europe Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Neurosurgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Europe 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 95: France Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: France Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: France 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: France Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: France 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: France Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: France 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 104: Germany Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Germany 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Germany 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 110: Germany Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Germany Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Germany 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 113: Italy Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Italy 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Italy 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 119: Italy Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: Italy Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: Italy 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 122: UK Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: UK Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: UK 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: UK Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: UK 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 128: UK Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: UK Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: UK 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
TABLE 131: Spain Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Spain Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Spain 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 134: Spain Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Spain Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Spain 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 137: Spain Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Spain Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Spain 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
TABLE 140: Russia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Russia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Russia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 143: Russia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Russia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Russia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 146: Russia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Russia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Russia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Rest of Europe 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of Europe 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Rest of Europe 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Neurosurgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Asia-Pacific 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Asia-Pacific 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Asia-Pacific 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Asia-Pacific 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 170: Australia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Australia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Australia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 173: Australia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Australia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Australia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 176: Australia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Australia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Australia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 179: India Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: India Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: India 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 182: India Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: India Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: India 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 185: India Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: India Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: India 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 188: South Korea Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: South Korea Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: South Korea 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 191: South Korea Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: South Korea Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: South Korea 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 194: South Korea Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: South Korea Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: South Korea 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Asia-Pacific Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Asia-Pacific Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Rest of Asia-Pacific Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 206: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Neurosurgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Latin America 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 209: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Latin America 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 212: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Latin America Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Latin America 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 215: Latin America Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Latin America Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Latin America 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 218: Argentina Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Argentina Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Argentina 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 221: Argentina Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Argentina Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Argentina 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 224: Argentina Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Argentina Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Argentina 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
TABLE 227: Brazil Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Brazil Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Brazil 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 230: Brazil Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Brazil Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Brazil 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 233: Brazil Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Brazil Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Brazil 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
TABLE 236: Mexico Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Mexico Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Mexico 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 239: Mexico Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Mexico Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Mexico 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 242: Mexico Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Mexico Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Mexico 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Rest of Latin America Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Rest of Latin America 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Rest of Latin America Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Rest of Latin America 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Rest of Latin America Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Rest of Latin America 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 254: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Neurosurgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Middle East 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 257: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Middle East 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 260: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Middle East Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Middle East 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 263: Middle East Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Middle East Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Middle East 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
IRAN
TABLE 266: Iran Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Iran Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Iran 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 269: Iran Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Iran Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Iran 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 272: Iran Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Iran Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Iran 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
TABLE 275: Israel Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Israel Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Israel 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 278: Israel Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Israel Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Israel 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 281: Israel Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Israel Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Israel 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: Saudi Arabia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: Saudi Arabia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: Saudi Arabia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: Saudi Arabia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: Saudi Arabia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: Saudi Arabia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 293: UAE Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: UAE Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: UAE 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 296: UAE Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: UAE Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: UAE 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 299: UAE Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: UAE Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: UAE 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: Rest of Middle East Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: Rest of Middle East 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Middle East Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Middle East 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Rest of Middle East Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Rest of Middle East 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 311: Africa Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 312: Africa Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 313: Africa 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
TABLE 314: Africa Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 315: Africa Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 316: Africa 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
TABLE 317: Africa Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 318: Africa Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 319: Africa 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030